Similar articles

• Systemic lupus erythematosus and accelerated atherosclerosis.

  Hahn BH. Hahn BH. N Engl J Med. 2003 Dec 18;349(25):2379-80. doi: 10.1056/NEJMp038168. N Engl J Med. 2003. PMID: 14681501 No abstract available.
• Risks and benefits of statins in lupus erythematosus.

  Noël B. Noël B. Arch Intern Med. 2004 Jan 12;164(1):107-8. doi: 10.1001/archinte.164.1.107-b. Arch Intern Med. 2004. PMID: 14718334 No abstract available.
• Should all patients with systemic lupus erythematosus receive cardioprotection with statins?

  Toloza S, Urowitz MB, Gladman DD. Toloza S, et al. Nat Clin Pract Rheumatol. 2007 Oct;3(10):536-7. doi: 10.1038/ncprheum0593. Nat Clin Pract Rheumatol. 2007. PMID: 17700557 No abstract available.
• Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?

  Bruce IN. Bruce IN. Best Pract Res Clin Rheumatol. 2005 Oct;19(5):823-38. doi: 10.1016/j.berh.2005.05.001. Best Pract Res Clin Rheumatol. 2005. PMID: 16150405 Review.
• Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials.

  Ye Y, Zhao X, Xie H, Tian Z, Zhang S. Ye Y, et al. Int J Cardiol. 2013 Jul 15;167(1):301-3. doi: 10.1016/j.ijcard.2012.09.190. Epub 2012 Oct 16. Int J Cardiol. 2013. PMID: 23084817 Review. No abstract available.